Association between hepatitis C and hepatocellular carcinoma, J Glob Infect Dis, vol.1, pp.33-40, 2009. ,
Hepatitis C virus-induced hepatocellular carcinoma, Clin Mol Hepatol, vol.21, pp.105-119, 2015. ,
Early occurrence and recurrence of hepatocellular carcinoma in HCV-related cirrhosis treated with direct-acting antivirals, J Hepatol, vol.65, pp.727-760, 2016. ,
Risk of hepatocellular carcinoma after sustained virological response in Veterans with hepatitis C virus infection, Hepatology, vol.64, pp.130-137, 2016. ,
, World Health Organization. Hepatitis C: fact sheet, 2016.
Impact of hepatitis C virus infection on all-cause and liver-related mortality in a large community-based cohort of inner city residents, J Viral Hepat, vol.18, pp.32-41, 2011. ,
All-cause and liver-related mortality in hepatitis C infected drug users followed for 33 years: A controlled study, Journal of Hepatology, vol.58, issue.1, pp.31-37, 2013. ,
Hospitalizations And Costs Associated With Hepatitis C And Advanced Liver Disease Continue To Increase, Health Affairs, vol.33, issue.10, pp.1728-1735, 2014. ,
Mortality, hospitalization, and quality of life among patients with hepatitis c infection on hemodialysis, Clin J Am Soc Nephrol, vol.12, pp.287-97, 2017. ,
Patterns of Healthcare Utilization Among Veterans Infected With Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV) and Coinfected With HIV/HCV: Unique Burdens of Disease, Open Forum Infectious Diseases, vol.3, issue.3, p.173, 2016. ,
National estimates of healthcare utilization by individuals with hepatitis C virus infection in the United States, Clin Infect Dis, vol.59, pp.755-64, 2014. ,
The spread of hepatitis C virus genotype 1a in North America: a retrospective phylogenetic study, Lancet Infect Dis, vol.16, pp.698-702, 2016. ,
Hospitalisation for an alcohol-related cause among injecting drug users in Scotland: increased risk following diagnosis with hepatitis C infection, Int J Drug Policy, vol.22, pp.63-72, 2011. ,
Impact of disease severity on healthcare costs in patients with chronic hepatitis C (CHC) virus infection, Hepatology, vol.56, pp.1651-60, 2012. ,
Inpatient resource utilization, disease severity, mortality and insurance coverage for patients hospitalized for hepatitis C virus in the United States, J Viral Hepat, vol.22, pp.137-182, 2015. ,
The HCV epidemics in key populations (including PWID, prisoners, and MSM): the use of DAAs as treatment for prevention, Curr Opin HIV AIDS, vol.10, pp.374-80, 2015. ,
Safety and effectiveness of direct-acting antiviral agents for treatment of patients with chronic hepatitis C virus infection and cirrhosis, Clin Gastroenterol Hepatol, vol.14, pp.1821-1851, 2016. ,
Causes of hospital admission among people living with HIV worldwide: a systematic review and meta-analysis, Lancet HIV, vol.2, pp.438-444, 2015. ,
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement, BMJ, vol.339, p.2535, 2009. ,
Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement, Syst Rev, vol.4, p.1, 2015. ,
The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions, J Epidemiol Community Health, vol.52, pp.377-84, 1998. ,
Health outcomes associated with methamphetamine use among young people: a systematic review, Addiction, vol.105, pp.991-1002, 2010. ,
, Preferred reporting items for systematic reviews and metaanalyses, PRISMA flow diagram, 2017.